-
-
-
-
-
-
-
Goldman Sachs Starts Crinetics (CRNX) at Neutral
-
-
-
-
-
-
-
Crinetics Announces FDA Acceptance of New Drug Application for Paltusotine for Adult Patients with Acromegaly
-
14,982 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

